EN
HI
Summary
As of 10 Oct, 2026, Jagsonpal Pharmaceuticals stock price is ₹225.6. During the trading session, the stock has moved between an intraday low of ₹224.50 and an intraday high of ₹232.40. Over the last 52 weeks, Jagsonpal Pharmaceuticals has traded between ₹155.00 and ₹264.50.
The stock has recorded a trading volume of 50,851 shares,. Its Average Traded Price (ATP) is ₹227.59, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹225.60.
Jagsonpal Pharmaceuticals has an upper circuit limit of ₹270.72 and a lower circuit limit of ₹180.48. The total value traded stands at ₹1.16 CR, and the delivery percentage for the day is 47.88%.
The stock is currently traded with a market lot size of 1. Jagsonpal Pharmaceuticals also offers a dividend yield of 0%.
Jagsonpal Pharmaceuticals Share Price Chart
Jagsonpal Pharmaceuticals Share Key Metrics
Volume
50851.00
Market Cap
1488.00 CR
LTQ@LTP
1@225.60
ATP
227.59
Var Margin
19.61 %
Circuit Range
180.48-270.72
Delivery %
47.88 %
Value
1.16 CR
ASM/GSM
No
Market Lot
1
Jagsonpal Pharmaceuticals Resistance and Support
Pivot 232.77
Resistance
First Resistance
236.73
Second Resistance
241.75
Third Resistance
245.71
Support
First Support
227.75
Second Support
223.79
Third Support
218.77
Jagsonpal Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 09 2026 | 228.64 | 225.6 | -2.63% | 232.4 | 224.5 |
| Thu Oct 08 2026 | 236.89 | 231.69 | -1.57% | 237.78 | 228.8 |
| Wed Oct 07 2026 | 234.8 | 235.39 | 0.75% | 243.46 | 234.8 |
Jagsonpal Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-29 | Quarterly Results |
| 2026-04-27 | Audited Results & Final Dividend |
| 2026-03-12 | Buy Back of Shares |
| 2026-01-21 | Quarterly Results |
| 2025-11-03 | Quarterly Results |
| 2025-07-26 | Quarterly Results |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-01-22 | Quarterly Results |
| 2024-10-23 | Quarterly Results & Stock Split |
| 2024-08-07 | Quarterly Results |
Jagsonpal Pharmaceuticals News
Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Jagsonpal Pharmaceuticals has successfully completed the acquisition of the wellness portfolio of Group Pharmaceuticals Limited. The deal involves an upfront consideration of Rs.23.7 crore, with the acquired business generating Rs.24.6 crore in FY26 revenue.
Oct 01 2026 16:57:25
Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Acquisition
Jagsonpal Pharmaceuticals acquired the Wellness Portfolio of Group Pharmaceuticals Limited for an initial Rs.23.7 crores, with total consideration up to Rs.46.7 crores. This acquisition aims to strengthen the company's pharmaceutical portfolio, particularly in women's health.
Sep 23 2026 17:52:39
Jagsonpal Pharmaceuticals Management
| Name | Position |
|---|---|
| Pratham Rawal | Company Secretary & Compliance Officer |
| Harsha Raghavan | Chairperson |
Jagsonpal Pharmaceuticals Similar Stocks
Fermenta Biotech Ltd.
517.55
-22.05 (4.09%)
Q-Line Biotech Ltd.
636.20
-19.55 (2.98%)
Amrutanjan Health Care Ltd.
508.90
5.85 (1.16%)
Anlon Healthcare Ltd.
28.11
1.33 (4.97%)
Gujarat Kidney And Super Speciality Ltd.
184.09
3.38 (1.87%)
Shalby Ltd.
131.84
1.42 (1.09%)
3B Blackbio Dx Ltd.
1586.40
56.40 (3.69%)
KMC Speciality Hospitals (India) Ltd.
169.77
-7.51 (4.24%)
Kopran Ltd.
251.05
-3.25 (1.28%)
Bharat Parenterals Ltd.
1864.00
-28.80 (1.52%)
Jagsonpal Pharmaceuticals FAQs
The Buying Price of Jagsonpal Pharmaceuticals share is 225.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Jagsonpal Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jagsonpal Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Jagsonpal Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Jagsonpal Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Jagsonpal Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.33 & 3.47 with sector averages, along with growth rates and financial metrics.
The Market Cap of Jagsonpal Pharmaceuticals is 1488.00 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Jagsonpal Pharmaceuticals share price is 264.50 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Jagsonpal Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in JAGSNPHARM
Or Download Choice FinX App
Invest in JAGSNPHARM
